You are here

gene therapy

Ophthotech becomes Iveric in pivot to gene therapies

Ophthotech becomes Iveric in pivot to gene therapies

Fierce Biotech

Flag link:

Adverum Bio offers a late notification about FDA hold on lead gene therapy for wet AMD

Adverum Bio offers a late notification about FDA hold on lead gene therapy for wet AMD

Endpoints

Adverum Biotechnologies

wet age-related macular degeneration

Flag link:

Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon

Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon

Xconomy

Paragon Bioservices

Flag link:

How Are Gene Therapies Going To Get Paid For?

How Are Gene Therapies Going To Get Paid For?

Forbes

value-based contracts

Flag link:

Lonza's CEO on keeping up with microbiome, gene therapy boom

Lonza's CEO on keeping up with microbiome, gene therapy boom

Biopharma Dive

drug manufacturing

Flag link:

Syncona gene therapy start-ups Gyroscope, Orbit merge

Syncona gene therapy start-ups Gyroscope, Orbit merge

BioCentury

retinal disease

Flag link:

AskBio Reels In $235M to Advance Gene Therapy Clinical Trials

AskBio Reels In $235M to Advance Gene Therapy Clinical Trials

Xconomy

Asklepios BioPharmaceutical

Flag link:

Gene therapies for the cats and dogs you love? Penn-partnered Scout Bio just raised $20M to make it a reality

Gene therapies for the cats and dogs you love? Penn-partnered Scout Bio just raised $20M to make it a reality

Endpoints

Flag link:

Novartis' SMA gene therapy would not be cost-effective if priced over $1.5M: ICER

Novartis' SMA gene therapy would not be cost-effective if priced over $1.5M: ICER

Fierce Pharma

spinal muscular atrophy

Flag link:

Does Sangamo Have the Best Gene Therapy Program Now?

Does Sangamo Have the Best Gene Therapy Program Now?

Motley Fool

Sangamo Therapeutics

Flag link:

Roche must ask Spark shareholders once again to sell

Roche must ask Spark shareholders once again to sell

Biopharma Dive

Spark Therapeutics

Flag link:

2 Blockbuster Gene Therapy Programs to Watch in 2019

2 Blockbuster Gene Therapy Programs to Watch in 2019

Motley Fool

Flag link:

Takeda takes a cautious step into neurological gene therapy, inking preclinical deal with StrideBio

Takeda takes a cautious step into neurological gene therapy, inking preclinical deal with StrideBio

Endpoints

Flag link:

First gene therapy to treat rare blood disease nears European approval

First gene therapy to treat rare blood disease nears European approval

Stat

beta-thalassemia

Flag link:

Gene therapy company Prevail raises $50M series B

Gene therapy company Prevail raises $50M series B

BioCentury

Prevail Therapeutics

neurodegenerative disease

Flag link:

Bluebird opens manufacturing facility as it moves gene therapies forward

Bluebird opens manufacturing facility as it moves gene therapies forward

Fierce Pharma

drug manufacturing

Flag link:

Thermo Bags Brammer For $1.7B as Gene Therapy Deal Spree Continues

Thermo Bags Brammer For $1.7B as Gene Therapy Deal Spree Continues

Xconomy

Flag link:

bluebird bio to Cut Ribbon on New Gene Therapy Factory in Durham, NC; Plans to Hire

bluebird bio to Cut Ribbon on New Gene Therapy Factory in Durham, NC; Plans to Hire

BioSpace

drug manufacturing

Flag link:

Pfizer buys stake in French gene therapy firm Vivet

Pfizer buys stake in French gene therapy firm Vivet

CNBC

Flag link:

Gene therapy progress spurs competition in biotech buyouts

Gene therapy progress spurs competition in biotech buyouts

Biopharma Dive

Nightstar Therapeutics

Spark Therapeutics

Flag link:

Pages